India's Cipla Second To U.S.-Based Abbott In First-Half Sales Growth
This article was originally published in PharmAsia News
Executive Summary
India's retail sales of pharmaceuticals increased by nearly one-fifth during the first six months of this year, with U.S.-based Abbott Laboratories claiming most the credit